DL-Glyceraldehyde 3-phosphate - 45-55 mg/mL aqueous solution
CAS: 591-59-3
Ref. 3D-MG46662
2mg | 149,00 € | ||
5mg | 206,00 € | ||
10mg | 358,00 € | ||
25mg | 495,00 € | ||
50mg | 820,00 € |
Información del producto
- (2-Hydroxy-3-oxopropyl) dihydrogen phosphate
- (2-Hydroxy-3-oxopropoxy)phosphonic acid
- 2-Hydroxy-3-(phosphonooxy)propanal
- 3-Phosphoglyceraldehyde
- 3-Phosphoroglyceric aldehyde
- 3-fosfato de DL-gliceraldehido
- 3-phosphate de DL-glyceraldehyde
- <span class="text-smallcaps">DL</span>-Glyceraldehyde 3-phosphate
- DL-Glyceraldehyd-3-phosphat
- DL-glyceraldehyde 3-phosphate
- Ver más sinónimos
- Glyceraldehyde, 3-(dihydrogen phosphate), <span class="text-smallcaps">DL</span>-
- Glyceraldehyde, 3-(dihydrogen phosphate), DL-
- Phosphoglyceraldehyde
- Propanal, 2-hydroxy-3-(phosphonooxy)-
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is an enzyme that catalyzes the conversion of glyceraldehyde-3-phosphate to 1,3 bisphosphoglycerate. GAPDH is involved in glycolysis and the pentose phosphate pathway. It has been shown to be an important player in mediating cellular responses to hypoxia, inflammation, and oxidative stress. The glyceraldehyde-3-phosphate dehydrogenase gene has been found to be mutated in a number of cancers including breast cancer and colon cancer. This gene also has a role in inflammatory lesion development as well as energy metabolism. GAPDH also participates in the biochemical reactions that lead to neuronal death during neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
The wild type strain of GAPDH is encoded by a single gene with three exons (exon 1, 2 and 3).
Propiedades químicas
Consulta técnica sobre: 3D-MG46662 DL-Glyceraldehyde 3-phosphate - 45-55 mg/mL aqueous solution
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.